1 Min Read
Jan 31 (Reuters) - Starpharma Holdings Ltd:
* RECEIVED REGULATORY AND ETHICS APPROVAL TO COMMENCE ITS PHASE-1/2 CLINICAL TRIAL DOE DEP CABAZITAXEL Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.